Related Experiment Video
Updated: Jun 22, 2026

Assessing Therapeutic Angiogenesis in a Murine Model of Hindlimb Ischemia
Published on: June 8, 2019
Vasodilator response correlates with outcome in chronic critical limb ischemia
Akihito Muto1, Yuka Kondo, Jose M Pimiento
1Department of Surgery, Yale University School of Medicine, New Haven, Connecticut, USA.
Insights
Skin perfusion pressure (SPP) measurements after vasodilator treatment can predict limb salvage in critical limb ischemia (CLI) patients. Improved SPP indicates a better prognosis for limb salvage, aiding clinical decision-making.
Area of Science:
- Vascular Medicine
- Clinical Diagnostics
- Regenerative Medicine
Background:
- Critical limb ischemia (CLI) presents a significant challenge due to limited predictors for successful limb salvage.
- Skin perfusion pressure (SPP) is a potential diagnostic tool, but its predictive value in response to vasodilation requires further investigation.
Purpose of the Study:
- To evaluate the accuracy of skin perfusion pressure (SPP) measurements in predicting limb salvage for patients with critical limb ischemia (CLI).
- To assess the correlation between SPP changes after vasodilator administration and clinical outcomes in CLI patients.
Main Methods:
- Patients diagnosed with CLI underwent baseline SPP measurements.
- SPP was reassessed at 120 minutes and 7 days after the administration of the vasodilator alprostadil.
Main Results:
- Patients who experienced clinical improvement showed a significant increase in SPP post-vasodilation (120 min: P < 0.01; day 7: P < 0.01).
- Conversely, patients with clinical deterioration exhibited no significant increase in SPP after vasodilator treatment (120 min: P = 0.086; day 7: P = 0.22).
Conclusions:
- Prognosis for limb salvage in CLI patients correlates with SPP improvement following vasodilator treatment at both early and late time points.
- Measuring SPP after vasodilator administration may offer clinical utility in managing CLI patients.
- Further multi-center trials are recommended to validate the use of SPP in response to vasodilators for CLI treatment.
Background:
There are few predictors of limb salvage in patients with critical limb ischemia (CLI). We evaluated the accuracy of correlation of skin perfusion pressure (SPP) measurements in response to vasodilation to clinical outcome.
Methods:
Patients with CLI were evaluated by SPP at baseline. After injection of the vasodilator alprostadil, SPP was re-evaluated at 120 min and at day 7.
Results:
Patients showing clinical improvement demonstrated increased SPP in response to vasodilation (120 min: 34.12+/-2.44 to 48.33+/-3.41 mm Hg, P < 0.01; day 7: 33.13+/-3.14 to 45.83+/-3.79 mm Hg, P < 0.01), whereas patients who clinically deteriorated demonstrated no increase in SPP (120 min: 30.00+/-2.67 to 35.00+/-2.31 mm Hg, P = 0.086; day 7: 35.00+/-3.54 to 27.5+/-4.33 mm Hg, P = 0.22).
Conclusions:
Prognosis for limb salvage correlated with SPP improvement post-vasodilator treatment after both early and late time points. Measurement of SPP after vasodilator treatment may be clinically useful in the treatment of patients with CLI. A multi-center trial of SPP in response to vasodilators is warranted.
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease III: Interprofessional Care

